These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38041790)

  • 1. Intrinsic Wave Velocity Propagation: A Novel Parameter for Assessing the Effect of Anthracycline Chemotherapy Agents on Cardiac Diastolic Function in Breast Cancer Patients.
    Huang X; Fan XY; Cheng Q; Zhang J; Sun J; Tang QY; Deng YB; Bi XJ
    Curr Med Sci; 2023 Dec; 43(6):1229-1237. PubMed ID: 38041790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy.
    Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Clarke JL; Thomas L
    Eur Heart J Cardiovasc Imaging; 2013 Mar; 14(3):228-34. PubMed ID: 22782955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study.
    Boyd A; Stoodley P; Richards D; Hui R; Harnett P; Vo K; Marwick T; Thomas L
    PLoS One; 2017; 12(4):e0175544. PubMed ID: 28407011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial reservoir longitudinal strain and its incremental value to the left ventricular global longitudinal strain in predicting anthracycline-induced cardiotoxicity.
    Li Z; Zhao R; Zhang Q; Shen Y; Shu X; Cheng L
    Echocardiography; 2024 Apr; 41(4):e15805. PubMed ID: 38558436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer.
    Arciniegas Calle MC; Sandhu NP; Xia H; Cha SS; Pellikka PA; Ye Z; Herrmann J; Villarraga HR
    BMC Cancer; 2018 Oct; 18(1):1037. PubMed ID: 30359235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines.
    Barbosa MF; Fusco DR; Gaiolla RD; Werys K; Tanni SE; Fernandes RA; Ribeiro SM; Szarf G
    BMC Cardiovasc Disord; 2021 Apr; 21(1):170. PubMed ID: 33845778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-dimensional speckle tracking echocardiography help identify breast cancer therapeutics-related cardiac dysfunction.
    Liu W; Li W; Li H; Li Z; Zhao P; Guo Z; Liu C; Sun L; Wang Z
    BMC Cardiovasc Disord; 2022 Dec; 22(1):548. PubMed ID: 36522712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speckle tracking echocardiography predicts early subclinical anthracycline cardiotoxicity in patients with breast cancer.
    Tang Q; Jiang Y; Xu Y; Xia H
    J Clin Ultrasound; 2017 May; 45(4):222-230. PubMed ID: 27910996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of echocardiography to monitor myocardial damage during anthracycline chemotherapy.
    Anqi Y; Yu Z; Mingjun X; Xiaoli K; Mengmeng L; Fangfang L; Mei Z
    Echocardiography; 2019 Mar; 36(3):495-502. PubMed ID: 30636342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Global Cardiac Function Using AutoSTRAIN Automatic Strain Quantitative Technology in Patients With Breast Cancer Undergoing Anthracycline-Based Chemotherapy.
    Gu J; Wang D; Jiang L; Huang Y; Ding L; Chen X; He Y; Zhou Z; Pu D
    Ultrasound Med Biol; 2023 Jan; 49(1):368-374. PubMed ID: 36283937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility.
    Santoro C; Arpino G; Esposito R; Lembo M; Paciolla I; Cardalesi C; de Simone G; Trimarco B; De Placido S; Galderisi M
    Eur Heart J Cardiovasc Imaging; 2017 May; 18(8):930-936. PubMed ID: 28379383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
    Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Byth K; Stuart K; Clarke JL; Thomas L
    Eur J Cancer; 2013 Nov; 49(16):3396-403. PubMed ID: 23937961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction.
    Zhang KW; Finkelman BS; Gulati G; Narayan HK; Upshaw J; Narayan V; Plappert T; Englefield V; Smith AM; Zhang C; Hundley WG; Ky B
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1059-1068. PubMed ID: 29550306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity.
    Nabati M; Janbabai G; Baghyari S; Esmaili K; Yazdani J
    J Cardiovasc Pharmacol; 2017 May; 69(5):279-285. PubMed ID: 28141699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal Global Longitudinal Strain During Anthracycline Treatment Predicts Future Cardiotoxicity in Children.
    Gunsaulus M; Alsaied T; Tersak JM; Friehling E; Rose-Felker K
    Pediatr Cardiol; 2024 Dec; 45(8):1750-1758. PubMed ID: 37606650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Impact of Global Longitudinal Strain and NT-proBNP on Early Development of Cardiotoxicity in Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy.
    Muckiene G; Vaitiekus D; Zaliaduonyte D; Zabiela V; Verseckaite-Costa R; Vaiciuliene D; Juozaityte E; Jurkevicius R
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241185
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of biventricular systolic strain derived from the two-dimensional and three-dimensional speckle tracking echocardiography in lymphoma patients after anthracycline therapy.
    Song FY; Shi J; Guo Y; Zhang CJ; Xu YC; Zhang QL; Shu XH; Cheng LL
    Int J Cardiovasc Imaging; 2017 Jun; 33(6):857-868. PubMed ID: 28255826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancer.
    Liu Z; Liu M; Zhong X; Qin Y; Liang T; Luo T; Yan X; Tang Z; Wang X; Liang S; Li Q; Ruan X; He W; Huang H
    Cancer Med; 2023 Jun; 12(12):13374-13387. PubMed ID: 37183826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late cardiac effect of anthracycline therapy in physically active breast cancer survivors - a prospective study.
    Nagy AC; GulAcsi-BArdos P; CserEp Z; Hangody L; Forster T
    Neoplasma; 2017; 64(1):92-100. PubMed ID: 27881009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of speckle tracking echocardiography to detect late anthracycline-induced cardiotoxicity in childhood cancer: A prospective controlled cross-sectional study.
    Amedro P; Vincenti M; Abassi H; Lanot N; De La Villeon G; Guillaumont S; Gamon L; Mura T; Lopez-Perrin K; Haouy S; Sirvent A; Cazorla O; Vergely L; Lacampagne A; Avesani M; Sirvent N; Saumet L
    Int J Cardiol; 2022 May; 354():75-83. PubMed ID: 35167907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.